Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor

doi:10.3748/wjg.v11.i6.875

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2376)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

267

HTML

1902

Figures (1-4)

207

Sum=2376

Feb 14, 2005 (publication date) through Aug 28, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 14, 2005; 11(6): 875-879
Published online Feb 14, 2005. doi: 10.3748/wjg.v11.i6.875

Full Size Figure Download Figure

Figure 4 Immunocytochemical staining of VEGF in two human stomach adenocarcinoma cell lines (DAB×400). A: parental cell line SGC7901; B: drug-resistant cell line SGC7901/R.

Citation: Yu LF, Cheng Y, Qiao MM, Zhang YP, Wu YL. Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor. World J Gastroenterol 2005; 11(6): 875-879
URL: https://www.wjgnet.com/1007-9327/full/v11/i6/875.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i6.875